Sign in to continue:

Tuesday, February 17th, 2026

Thomson Medical Bets Big on Johor: 300-Bed Hospital Targets Medical Tourism Boom in JS-SEZ

Johor Bahru could soon rival Kuala Lumpur and Penang as a major medical hub, as healthcare players, including Thomson Medical Group, eye the Johor-Singapore Special Economic Zone (JS-SEZ) for expansion.

Thomson Medical, controlled by Singaporean billionaire Peter Lim, is developing Thomson Hospital Iskandariah, a multi-specialty, 300-bed hospital that could scale up to 400 beds. The project will sit on a 1.5-hectare site and will be part of a larger 10-hectare landbank in Johor owned by the group.

The hospital will focus on key specialties such as oncology, orthopaedics, and obstetrics and gynaecology. Construction is set to begin by late 2025 or early 2026, with the full healthcare hub expected to be completed by 2030.

Group CEO Dr Melvin Heng noted that the JS-SEZ’s announcement was a key catalyst to revive the project after years of “starts and stops.” “The timing couldn’t be better,” he told The Business Times.

Thomson Medical is exploring partnerships for a second healthcare-related block adjacent to the hospital, seeking collaborators such as private medical groups, medical device makers, and clinical research organisations.

The project, initially estimated at RM1.2 billion (S$359.7 million) pre-Covid, will likely exceed this figure due to rising construction costs, which could climb as much as 30%, Dr Heng said.

Strategically located near the Johor Bahru-Singapore Rapid Transit System (RTS) Link, the Causeway, and the Johor-Batam ferry terminal, the hospital aims to tap into medical tourist flows from Singapore and Indonesia, while primarily serving Johor’s local community.

Dr Heng expects local patients to make up 60% to 65% of the hospital’s clientele, with Singaporeans accounting for 5% to 10%, calling it “quite significant” for a cross-border medical facility.

While congestion at the Causeway remains a concern, Dr Heng highlighted that both governments are working to ease traffic as part of broader JS-SEZ efforts.

“Between Kuala Lumpur and Singapore, there’s nothing strong,” he said. “Johor Bahru is the biggest city in between, and I think there’s plenty of room for growth.”

Thomson Medical’s move adds to a growing list of healthcare providers investing in Johor. These include IHH Healthcare, HMI Medical, KPJ Healthcare, and reportedly, Sunway, which is also eyeing a hospital in the area.

With Malaysia’s healthcare sector primed for expansion and medical tourism on the rise, Dr Heng is confident that Johor is well-positioned to become a leading medical destination in the region.

Thank you

Navigating Challenges and Opportunities: An In-Depth Analysis of ASTRO MK’s Financial Performance and Strategic Outlook

ASTRO MK Overview Date: September 30, 2024Broker: CGS International Securities Financial Performance ASTRO MK experienced a significant decline in its core net profit for 2QFY25, dropping 47% quarter-over-quarter (qoq) and 72% year-over-year (yoy). For...

Tencent Holdings Stock Analysis: Strong Bullish Trend and Technical Buy Signal

Comprehensive Analysis of Hong Kong Retail Stocks – November 6, 2024 Comprehensive Analysis of Hong Kong Retail Stocks – November 6, 2024 By CGS International Overview of Market Trends The global markets experienced significant...

Singapore Airlines (SIA) 2025-2026 Outlook: Downgrade to Reduce, Profit-Taking Advised Ahead of Dividend Ex-Date Amid Air India Losses

CGS International July 28, 2025 Singapore Airlines Faces Turbulence Ahead: Downgrade, Profit Taking Advised Before Dividend Ex-Date Executive Summary CGS International has downgraded Singapore Airlines (SIA) from “Hold” to “Reduce,” citing underperformance in the...

   Ad